Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. - Wikidata - awgldk - TriplyDB

Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.

Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.

http://www.wikidata.org/entity/Q45867094

about

Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics Laser capture microdissection technology Reverse phase protein microarrays advance to use in clinical trials Application of proteomics to soft tissue sarcomas Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing's sarcoma cells for apoptosis Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancer Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo.Phosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology.EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors.Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas.Rapamycin pharmacokinetic and pharmacodynamic relationships in osteosarcoma: a comparative oncology study in dogs Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells.2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma.A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data.Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation FANCD2 is a potential therapeutic target and biomarker in alveolar rhabdomyosarcoma harboring the PAX3-FOXO1 fusion gene.Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group.Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program.Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment.Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer Laser capture microdissection for protein and NanoString RNA analysis Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis.Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma.High resolution mapping of the cardiac transmural proteome using reverse phase protein microarrays Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?Applications of protein microarrays for biomarker discovery.Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.

P2860

Q26825000-8B7819CB-8ACB-4DF4-9F26-34B4027E34FF Q27025953-30B3552E-739E-42D3-8597-ACC85DAD8937 Q28250373-4DEA6FC6-FE37-4219-89CC-50A9DFF170B3 Q28384553-222564E5-020E-437E-BE22-ED420ADA7A32 Q28385995-D3301FA2-7444-4292-B02A-95EDF82CAB61 Q28396457-DACCFB91-780F-4BF3-815B-C5DCFF368049 Q28397404-3B88BA35-9BF4-4860-99AA-1771E70B8C11 Q28475897-C5CF9460-F6E2-4816-8DD3-C7ACBECDA2E5 Q30395770-550502F7-6B95-40CB-AD70-13248F22FB7E Q30425261-E1CACC71-9661-4457-B7DB-F0B29554DD82 Q30427044-6239D0A6-E12C-4644-89E3-F7522240718F Q30450696-C93EF915-7FD3-405D-85F0-41DDF00FCB67 Q33273472-E946D182-F851-4149-B076-DBD760223A48 Q33358603-5D11CA97-5F4E-457C-A133-CBCF1FE01AA2 Q33416583-4B95B385-2B0F-4CE4-A647-D6B366734CE0 Q33514778-ED696AF2-B8D0-4768-8063-BD83268EC620 Q33603032-7FEB1C37-62FC-4C4D-AB8F-7E6284571E52 Q33640816-0C09A750-9D9E-4183-95D5-91ED2F7D3EB7 Q33708023-F0E93D92-738E-494B-9A9E-64AD2A161204 Q33756595-EC9EF3FB-8A7B-433E-9FB5-ECED5755D5EC Q33764664-6775B299-F876-4920-9235-A9A07A21FCAD Q33795593-14881D44-8393-497C-8FC9-97127735AC02 Q33850616-9F173A88-3052-44A9-90E2-009C404E5357 Q33866426-8DC77F63-497C-4372-B68C-243EB99E73B2 Q33901255-FABDCE8F-AFA0-4995-A724-C6823C623443 Q33916861-E21677A5-028F-434F-A23E-980347A53D4D Q34149563-F07B09E4-E180-4962-8FD6-C9B6F6D8F43F Q34184286-C9EA24E6-A19F-4EC7-8F1E-A2F7F3E6A849 Q34196216-08CB870A-1834-4965-927E-BD273F232591 Q34249719-F335DD87-4DA2-4A1B-84E8-91F6CB8A75F2 Q34289736-76061EE8-3227-402E-9063-0702B7672133 Q34354775-A2141C09-C5F8-42E0-9A9B-5C3BC2FEA815 Q34425869-C6A86CA7-5053-4F70-AB2D-7990F64146C2 Q34550194-F0082E32-D1BA-41A9-9F66-50783F8FC632 Q35013574-68406FC9-7C94-4828-8912-AA2324D0C5FE Q35096201-98F34E30-3FFB-49EF-BD19-59284623D28A Q35098555-00B7396E-859A-4DC1-9CEB-2534B067E5C5 Q35161241-DFD2154E-07D6-443D-849C-34204E748317 Q35170387-614CC006-A0FD-4EB0-9F3C-11042D2885CE Q35586330-4B52B6FA-A4CA-44DE-9916-2BF7C1F7D8DE

P2860

Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival.

http://www.wikidata.org/entity/Q45867094

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@en

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@nl

type

label

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@en

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@nl

prefLabel

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@en

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@nl

P1433

Q45867094-20E1C30D-7685-4774-A826-65E44674D89D

P1476

Q45867094-A7AAAE03-2CDF-45E6-9001-F3C159F0403E

P2093

Q45867094-1BAA0DB4-2A1D-4526-86E6-45CF4C6C71B6

Q45867094-2236DB7B-DE69-495C-B707-DF0ECF8BEB69

Q45867094-26445675-D089-41BD-8B12-26AF1F13318B

Q45867094-41667635-4A04-472B-A854-C65DB6208073

Q45867094-4823F9C6-D7FB-45DD-86F9-C133254D4CC7

Q45867094-55598F5E-D83A-46F0-9FC1-763C6ED2164C

Q45867094-5F6EE488-BDC5-469C-BD2D-9D3B6EE0522F

Q45867094-68B8121C-EBEB-42A8-8C87-F84E985867DB

Q45867094-84E6D29F-2891-443D-A689-3BC6BF238DFF

Q45867094-ADD7D793-C3E2-489E-B2DA-C3A0679A2BCE

P304

Q45867094-466E80C1-71ED-40B4-A103-5725484BF553

P31

Q45867094-0B83C08C-937F-46BB-8895-5ABDBD75309E

P356

Q45867094-B605D448-8034-44CF-9877-7B44FC833C8B

P407

Q45867094-0BBA47AE-7444-4E8A-BA2C-8FEAFD71DD5A

P433

Q45867094-B4258C55-FDF2-40C8-B2E2-11DDC0695AEE

P478

Q45867094-54EFBD35-EF8A-4EB5-916E-5280FAEE6B60

P50

Q45867094-9FF1A126-D9A2-45F4-A408-32F034890A7A

P577

Q45867094-63071A95-97C2-4804-ABB7-D6614D6B5DC3

P5875

Q45867094-AC4D53B9-D1A5-4666-9A90-A3D2FCC011D4

P698

Q45867094-34EB8AD8-9E0B-4B57-B31B-B9411C18195C

P356

0008-5472.CAN-06-1344

P1433

Cancer Research

P1476

Phosphoprotein pathway mapping ...... ood rhabdomyosarcoma survival.

@en

P2093

Brieanne Midura

http://www.w3.org/2001/XMLSchema#string

Choh Yeung

http://www.w3.org/2001/XMLSchema#string

Donald J Johann

http://www.w3.org/2001/XMLSchema#string

Emanuel F Petricoin

http://www.w3.org/2001/XMLSchema#string

Gabriel S Eichler

http://www.w3.org/2001/XMLSchema#string

Kartik Krishnan

http://www.w3.org/2001/XMLSchema#string

Lance A Liotta

http://www.w3.org/2001/XMLSchema#string

Lee J Helman

http://www.w3.org/2001/XMLSchema#string

Maria Tsokos

http://www.w3.org/2001/XMLSchema#string

Robyn P Araujo

http://www.w3.org/2001/XMLSchema#string

P304

3431-3440

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-06-1344

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Virginia Espina

P577

2007-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6413406

http://www.w3.org/2001/XMLSchema#string

P698

17409454

http://www.w3.org/2001/XMLSchema#string